BIO-Europe is the must-attend global biopharma partnering event, bringing together industry leaders, innovators, and decision-makers from across the life sciences ecosystem. For over three decades, BIO-Europe has served as the premier platform for forging strategic partnerships, advancing groundbreaking collaborations, and driving the future of biopharma innovation.
This year marks a transformative milestone for BIO-Europe as it unveils a bold new vision for its 32nd annual conference, taking place in Cologne, Germany, November 9-11, 2026. Moving beyond its established position as Europe’s largest partnering event, BIO-Europe is evolving into the neutral, credible forum where the full biopharma C-suite shapes not only partnerships but the strategic direction of the industry worldwide.
As the biopharma landscape grows increasingly complex—spanning regulation, clinical development, manufacturing, policy, and financing—BIO-Europe 2026 responds with an expanded program designed for more connected, cross-functional decision-making. Building on its unwavering commitment to open dialogue, constructive partnerships, and recognition of the international nature of the life sciences industry, this year’s conference convenes the full suite of C-level strategy executives.
The renewed vision comes to life through:
- Convening the entire biopharma C-suite
- Seven integrated tracks expanding beyond partnering and investment to encompass regulatory developments, clinical affairs, and biomanufacturing strategy.
- Daily plenary sessions on macro-level industry and policy trends impacting life science leadership.
- New access options to support different levels of delegate engagement.
At the heart of this vision is our unwavering commitment to global collaboration. BIO-Europe 2026 stands for open dialogue, building partnerships, and advancing R&D that improves patient outcomes worldwide.
